TZ Ref No.: TZ-26-1421067
Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement in accordance with Section 130c Paragraph 1 SGB V between IKK classic and CC Pharma GmbH for Emgality
Doc ref no.
ted_•••
Sector
Pharmaceuticals
Contract Date
10 Nov 2026
Contract Value
EUR ••••••
Contract Intelligence
AI opportunity notes and scope analysis for this contract award
Opportunity Notes
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Official Award Result
Status: Contract Awarded
Award Date: 10 Nov 2026
Awarded Contractor / Winner
CC P•••
Awarded Contract Value:
EUR 1.00
Contract Description
Conclusion of a non-exclusive discount agreement in accordance with Section 130c Paragraph 1 SGB V between IKK classic and CC Pharma GmbH for Emgality (active ingredient: Galcanezumab, ATC code: N02CD02), contract term: December 1st, 2026 - November 30th, 2028)